Any bacterial metabolite produced during a metabolic reaction in Mycoplasma genitalium.
| Member | Definition | Class |
|---|
| 2-deoxyglucose-6-phosphate | A deoxyaldohexose phosphate comprising 2-deoxy-D-glucose having the phosphate group at the 6-position. | 2-deoxy-D-glucose 6-phosphate |
| 2-phenyl-2-propanol | A tertiary alcohol that is isopropanol in which the hydrogen attached to the carbon bearing the hydroxy group has been replaced by a phenyl group. | 2-phenylpropan-2-ol |
| 2'-deoxycytidine diphosphate | A 2'-deoxycytidine phosphate that is the 2'- deoxy derivative of cytidine 5'-diphosphate (CDP). | dCDP |
| 5-(carboxymethylaminomethyl)-2-thiouridine | A thiouridine that is 2-thiouridine bearing an additional carboxymethylaminomethyl substituent at position 5 on the thiouracil ring. | 5-carboxymethylaminomethyl-2-thiouridine |
| 5,6-dihydrothymidine | A pyrimidine 2'-deoxyribonucleoside having dihydrothymine as the nucleobase. | 5,6-dihydrothymidine |
| 6-azathymine | A nucleobase analogue that is thymine in which the CH group at position 6 is replaced by nitrogen. | 6-azathymine |
| 8-azaadenine | A triazolopyrimidine that is [1,2,3]triazolo[4,5-d]pyrimidine bearing an amino substituent at position 7. | 8-azaadenine |
| 8,5'-cyclo-2'-deoxyadenosine | An organic heterotetracyclic compound obtained by intramolecular formation of a C-C bond between positions 8 and 5' of 2'-deoxyadenosine. | 8,5'-cyclo-2'-deoxyadenosine |
| 8,5'-cyclo-2'-deoxyguanosine | An organic heterotetracyclic compound obtained by intramolecular formation of a C-C bond between positions 8 and 5' of 2'-deoxyguanosine. | 8,5'-cyclo-2'-deoxyguanosine |
| adenosine 5'-phosphoramidate | The phosphoramadite analogue of AMP. | adenosine 5'-phosphoramidate |
| alanylalanine | A dipeptide consisting of two L-alanine units joined by a peptide linkage. | Ala-Ala zwitterion; L-alanyl-L-alanine |
| arginylarginine | A dipeptide formed from two L-arginine residues. | Arg-Arg |
| aspartyl-aspartic acid | A dipeptide formed from two L-aspartic acid units. | Asp-Asp |
| butyric acid | A straight-chain saturated fatty acid that is butane in which one of the terminal methyl groups has been oxidised to a carboxy group. | butyric acid |
| chloramphenicol | An organochlorine compound that is dichloro-substituted acetamide containing a nitrobenzene ring, an amide bond and two alcohol functions. | chloramphenicol |
| cifostodine | A 2',3'-cyclic pyrimidine nucleotide in which cytidine is the parent nucleoside. | 2',3'-cyclic CMP |
| cumene hydroperoxide | A peroxol that is cumene in which the alpha-hydrogen is replaced by a hydroperoxy group. | cumene hydroperoxide |
| cyclic diadenosine phosphate | A cyclic purine dinucleotide that is the 3',5'-cyclic dimer of AMP. | cyclic di-AMP |
| cysteinylcysteine | A dipeptide formed from two L-cysteine residues. | Cys-Cys |
| deoxydiguanosine diphosphosphate | A single-stranded DNA oligonucleotide comprising two 2'-deoxyguanosine residues connected by a 3'->5 linkage and with a phosphoric group at the 5'-terminus. | 5'-d(pGpG)-3' |
| deoxyinosine monophosphate | A deoxyinosine phosphate that is 5'-inosinic acid in which the hydroxy group at position 2' by a hydrogen atom. | 2'-deoxyinosine-5'-monophosphate |
| difloxacin | A quinolone that is pefloxacin in which the ethyl group at position 1 of the quinolone has been replaced by a p-fluorophenyl group. A broad-spectrum antibiotic effective against both Gram-positive and Gram-negative bacteria, it is used (usually as the monohydrochloride salt) for the treatment of bacterial infections in dogs. | difloxacin |
| glutamyl-glutamic acid | A dipeptide composed of two L-glutamic acid units joined by a peptide linkage. | Glu-Glu |
| histidylhistidine | A dipeptide formed from two L-histidine residues. | His-His |
| isodialuric acid | A nucleobase analogue that is uracil substituted at positions 5 and 6 by hydroxy groups. | 5,6-dihydroxyuracil |
| leucylleucine | A dipeptide formed from two L-leucine residues. | Leu-Leu zwitterion; Leu-Leu |
| lysyllysine | A dipeptide formed from two L-lysine residues. | Lys-Lys |
| menaquinone 7 | A menaquinone whose side-chain contains seven isoprene units in an all-trans-configutation. | menaquinone-7 |
| methanol | The primary alcohol that is the simplest aliphatic alcohol, comprising a methyl and an alcohol group. | methanol |
| n-palmitoylsphingosine | A N-acylsphingosine in which the ceramide N-acyl group is specified as hexadecanoyl (palmitoyl). | N-hexadecanoylsphingosine |
| phenylalanylphenylalanine | A dipeptide formed from two L-phenylalanine residues. | Phe-Phe zwitterion; Phe-Phe |
| prolyl-proline | A dipeptide formed from two L-proline residues. | Pro-Pro |
| s-adenosylmethionine | A sulfonium compound that is the S-adenosyl derivative of L-methionine. It is an intermediate in the metabolic pathway of methionine. | S-adenosyl-L-methionine zwitterion; S-adenosyl-L-methionine |
| streptogramin a | A macrolide that is (together with pristinamycin IA) a component of pristinamycin, an oral streptogramin antibiotic produced by Streptomyces pristinaespiralis. Pristinamycin exhibits bactericidal activity against Gram positive organisms including methicillin-resistant Staphylococcus aureus. | pristinamycin IIA |
| Trp-Trp | A dipeptide formed from two L-tryptophan residues. | Trp-Trp |
| tryptophyl adenylate | An L-tryptophan derivative that is the ester obtained by formal condensation of the carboxy group of L-tryptophan with the 3'-hydroxy group of AMP. | 3'-L-tryptophyl-AMP |
| tyrosyltyrosine | Tyrosyltyrosine in which each tyrosine residue has L-configuration. | Tyr-Tyr |
| valylvaline | A dipeptide formed from two L-valine residues. | Val-Val |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 15-lipoxygenase, partial | Homo sapiens (human) | Potency | 0.1259 | 1 | 1 |
| activating transcription factor 6 | Homo sapiens (human) | Potency | 31.2578 | 1 | 2 |
| aldehyde dehydrogenase 1 family, member A1 | Homo sapiens (human) | Potency | 26.9680 | 1 | 2 |
| AR protein | Homo sapiens (human) | Potency | 21.0160 | 4 | 4 |
| aryl hydrocarbon receptor | Homo sapiens (human) | Potency | 76.9588 | 1 | 1 |
| Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 15.3553 | 1 | 1 |
| cytochrome P450 2C9, partial | Homo sapiens (human) | Potency | 89.3584 | 1 | 1 |
| cytochrome P450 2D6 | Homo sapiens (human) | Potency | 89.3584 | 1 | 1 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | Homo sapiens (human) | Potency | 60.4043 | 1 | 2 |
| DNA polymerase iota isoform a (long) | Homo sapiens (human) | Potency | 89.1251 | 1 | 1 |
| estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 31.6751 | 4 | 7 |
| estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 26.6150 | 4 | 6 |
| euchromatic histone-lysine N-methyltransferase 2 | Homo sapiens (human) | Potency | 3.9811 | 1 | 1 |
| EWS/FLI fusion protein | Homo sapiens (human) | Potency | 0.0209 | 1 | 2 |
| farnesoid X nuclear receptor | Homo sapiens (human) | Potency | 27.2983 | 1 | 1 |
| G | Vesicular stomatitis virus | Potency | 89.3584 | 1 | 1 |
| geminin | Homo sapiens (human) | Potency | 0.0055 | 2 | 2 |
| GLI family zinc finger 3 | Homo sapiens (human) | Potency | 17.5714 | 2 | 3 |
| glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 8.4852 | 1 | 1 |
| heat shock protein beta-1 | Homo sapiens (human) | Potency | 56.4020 | 2 | 3 |
| histone acetyltransferase KAT2A isoform 1 | Homo sapiens (human) | Potency | 14.1626 | 1 | 2 |
| Histone H2A.x | Cricetulus griseus (Chinese hamster) | Potency | 44.9878 | 1 | 1 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | Homo sapiens (human) | Potency | 39.8107 | 1 | 1 |
| HLA class I histocompatibility antigen, B alpha chain | Homo sapiens (human) | Potency | 89.3584 | 1 | 1 |
| Inositol hexakisphosphate kinase 1 | Homo sapiens (human) | Potency | 89.3584 | 1 | 2 |
| Interferon beta | Homo sapiens (human) | Potency | 89.3584 | 1 | 1 |
| interleukin 8 | Homo sapiens (human) | Potency | 66.8242 | 1 | 1 |
| lamin isoform A-delta10 | Homo sapiens (human) | Potency | 17.7828 | 1 | 1 |
| lethal factor (plasmid) | Bacillus anthracis str. A2012 | Potency | 31.6228 | 1 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 48.5557 | 3 | 6 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | Homo sapiens (human) | Potency | 0.5004 | 1 | 2 |
| Nuclear receptor ROR-gamma | Homo sapiens (human) | Potency | 42.1632 | 1 | 1 |
| nuclear receptor ROR-gamma isoform 1 | Mus musculus (house mouse) | Potency | 35.4813 | 1 | 1 |
| nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 38.6689 | 2 | 3 |
| peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 24.5412 | 1 | 1 |
| pregnane X nuclear receptor | Homo sapiens (human) | Potency | 70.7946 | 1 | 1 |
| progesterone receptor | Homo sapiens (human) | Potency | 65.7398 | 1 | 1 |
| RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 48.9571 | 2 | 4 |
| regulator of G-protein signaling 4 | Homo sapiens (human) | Potency | 0.2119 | 1 | 1 |
| retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 45.6305 | 2 | 4 |
| SMAD family member 2 | Homo sapiens (human) | Potency | 23.0065 | 1 | 1 |
| SMAD family member 3 | Homo sapiens (human) | Potency | 23.0065 | 1 | 1 |
| TDP1 protein | Homo sapiens (human) | Potency | 9.3960 | 2 | 7 |
| thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 41.6810 | 3 | 4 |
| thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 30.9795 | 5 | 5 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | Homo sapiens (human) | Potency | 30.9610 | 3 | 4 |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 30S ribosomal protein S1 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 30S ribosomal protein S10 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 30S ribosomal protein S11 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 30S ribosomal protein S12 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 30S ribosomal protein S13 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 30S ribosomal protein S14 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 30S ribosomal protein S15 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 30S ribosomal protein S16 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 30S ribosomal protein S17 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 30S ribosomal protein S18 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 30S ribosomal protein S19 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 30S ribosomal protein S2 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 30S ribosomal protein S20 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 30S ribosomal protein S21 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 30S ribosomal protein S3 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 30S ribosomal protein S4 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 30S ribosomal protein S5 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 30S ribosomal protein S6 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 30S ribosomal protein S7 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 30S ribosomal protein S8 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 30S ribosomal protein S9 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L1 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L10 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L11 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L13 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L14 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L15 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L16 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L17 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L18 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L19 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L2 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L20 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L21 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L22 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L23 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L24 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L25 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L27 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L28 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L29 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L3 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L30 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L31 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L31 type B | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L32 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L33 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L34 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L35 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L36 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L36 2 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L4 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L5 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L6 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| 50S ribosomal protein L7/L12 | Escherichia coli K-12 | IC50 | 0.4300 | 1 | 1 |
| Angiotensin-converting enzyme | Homo sapiens (human) | IC50 | 616.5950 | 1 | 1 |
| ATP-binding cassette sub-family C member 3 | Homo sapiens (human) | IC50 | 133.0000 | 1 | 1 |
| Bile salt export pump | Homo sapiens (human) | IC50 | 408.6333 | 3 | 3 |
| Chain A, Nitrile Hydratase alpha subunit | Pseudonocardia thermophila | Ki | 1,300.0000 | 1 | 1 |
| Chain A, Oligo-peptide Binding Protein | Salmonella enterica subsp. enterica serovar Typhimurium | Ki | 125.0000 | 1 | 1 |
| Chain B, Nitrile Hydratase beta subunit | Pseudonocardia thermophila | Ki | 1,300.0000 | 1 | 1 |
| Cytochrome P450 3A4 | Homo sapiens (human) | Ki | 10.6000 | 1 | 1 |
| Endoplasmin | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
| Glutamate carboxypeptidase 2 | Rattus norvegicus (Norway rat) | IC50 | 0.7500 | 1 | 1 |
| Glutamate receptor 1 | Homo sapiens (human) | Ki | 260.0000 | 1 | 2 |
| Glutamate receptor 2 | Homo sapiens (human) | Ki | 260.0000 | 1 | 2 |
| Glutamate receptor 3 | Homo sapiens (human) | Ki | 260.0000 | 1 | 2 |
| Glutamate receptor 4 | Homo sapiens (human) | Ki | 260.0000 | 1 | 2 |
| Glutamate receptor ionotropic, kainate 3 | Rattus norvegicus (Norway rat) | Ki | 260.0000 | 1 | 2 |
| Heat shock protein HSP 90-alpha | Homo sapiens (human) | Ki | 3.0000 | 1 | 1 |
| Histone deacetylase 1 | Homo sapiens (human) | IC50 | 158.0000 | 2 | 2 |
| Histone deacetylase 1 | Homo sapiens (human) | Ki | 136.0000 | 1 | 1 |
| Histone deacetylase 11 | Homo sapiens (human) | Ki | 136.0000 | 1 | 1 |
| Histone deacetylase 2 | Homo sapiens (human) | IC50 | 206.0000 | 2 | 2 |
| Histone deacetylase 2 | Homo sapiens (human) | Ki | 136.0000 | 1 | 1 |
| Histone deacetylase 3 | Homo sapiens (human) | IC50 | 9.0000 | 1 | 1 |
| Histone deacetylase 3 | Homo sapiens (human) | Ki | 136.0000 | 1 | 1 |
| Histone deacetylase 4 | Homo sapiens (human) | IC50 | 2,000.0000 | 1 | 1 |
| Histone deacetylase 4 | Homo sapiens (human) | Ki | 136.0000 | 1 | 1 |
| Histone deacetylase 5 | Homo sapiens (human) | IC50 | 2,000.0000 | 1 | 1 |
| Histone deacetylase 5 | Homo sapiens (human) | Ki | 136.0000 | 1 | 1 |
| Histone deacetylase 6 | Homo sapiens (human) | IC50 | 2,000.0000 | 1 | 1 |
| Histone deacetylase 6 | Homo sapiens (human) | Ki | 136.0000 | 1 | 1 |
| Histone deacetylase 7 | Homo sapiens (human) | IC50 | 1,150.0000 | 2 | 2 |
| Histone deacetylase 7 | Homo sapiens (human) | Ki | 136.0000 | 1 | 1 |
| Histone deacetylase 8 | Homo sapiens (human) | IC50 | 15.0000 | 1 | 1 |
| Histone deacetylase 8 | Homo sapiens (human) | Ki | 136.0000 | 1 | 1 |
| Histone deacetylase 9 | Homo sapiens (human) | IC50 | 2,000.0000 | 1 | 1 |
| Histone deacetylase 9 | Homo sapiens (human) | Ki | 136.0000 | 1 | 1 |
| Lysine-specific demethylase 4E | Homo sapiens (human) | IC50 | 10,000.0000 | 1 | 1 |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | IC50 | 1,963.6364 | 1 | 11 |
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | IC50 | 133.0000 | 1 | 1 |
| Polyamine deacetylase HDAC10 | Homo sapiens (human) | Ki | 136.0000 | 1 | 1 |
| Solute carrier family 15 member 1 | Homo sapiens (human) | IC50 | 1,805.2500 | 2 | 12 |
| Solute carrier family 15 member 1 | Homo sapiens (human) | Ki | 569.7500 | 3 | 8 |
| Solute carrier family 15 member 1 | Rattus norvegicus (Norway rat) | Ki | 4,495.0000 | 1 | 2 |
| Solute carrier family 15 member 2 | Homo sapiens (human) | Ki | 43.9033 | 2 | 9 |
| Solute carrier family 15 member 2 | Rattus norvegicus (Norway rat) | Ki | 123.0000 | 1 | 2 |
| Solute carrier family 22 member 20 | Mus musculus (house mouse) | Ki | 81.6416 | 1 | 2 |
| Solute carrier family 22 member 6 | Mus musculus (house mouse) | Ki | 3,483.6850 | 1 | 2 |
| Thymidine kinase 2 | Rattus norvegicus (Norway rat) | Ki | 77.0000 | 1 | 1 |
| Tripeptidyl-peptidase 2 | Rattus norvegicus (Norway rat) | Ki | 1,670.0000 | 1 | 1 |
| Tyrosine--tRNA ligase, cytoplasmic | Homo sapiens (human) | IC50 | 3.8000 | 1 | 1 |